PDF(1171 KB)
Foxp3在神经母细胞瘤LA-N-6细胞的表达及化疗药物对其影响
孙婧, 李良, 肖燕, 余素明, 唐锁勤
中国当代儿科杂志 ›› 2010, Vol. 12 ›› Issue (05) : 386-389.
PDF(1171 KB)
PDF(1171 KB)
Foxp3在神经母细胞瘤LA-N-6细胞的表达及化疗药物对其影响
Neuroblastoma LA-N-6 cells express Foxp3 which can be suppressed by chemotherapeutic agents
目的：研究神经母细胞瘤细胞是否表达免疫逃逸相关分子Foxp3及其对化疗药物的敏感性。方法：体外培养神经母细胞瘤细胞株LA-N-6；MTT试验明确化疗药物环磷酰胺（CTX）、盐酸吡柔比星(THP)对LA-N-6的效应剂量,流式细胞术(FACS)及实时定量PCR（RT-PCR）测定Foxp3在LA-N-6中的表达和CTX、THP对LA-N-6中Foxp3表达的影响。结果：FACS结果显示LA-N-6细胞高表达Foxp3，加入 CTX、THP后显著降低了LA-N-6上Foxp3的表达（P<0.05）；RT-PCR显示CTX显著降低了LA-N-6细胞中Foxp3的表达（P<0.05），THP加药组与对照组比较差异无统计学意义。结论：肿瘤逃逸相关转录因子Foxp3高表达于神经母细胞瘤细胞LA-N-6；CTX、THP能分别在蛋白或基因水平降低Foxp3分子在LA-N-6的表达，提示CTX、THP可能通过抑制Foxp3分子的表达而抗肿瘤的作用。 ［中国当代儿科杂志，2010，12（5）：386-389］
OBJECTIVE: To investigate whether neuroblastoma cells LA-N-6 express Foxp3 and whether the expression of Foxp3 is sensitive to chemotherapy by cyclophosvnamide（CTX）and pirarubicin（THP）. METHODS: Expression of Foxp3 on LA-N-6 cells was examined by flow cytometry analysis. The dose-effects of chemotherapy drugs including CTX and THP on LA-N-6 cells were investigated by MTT assay. The effects of CTX and THP on Foxp3 expression were examined by flow cytometry and real-time PCR assays. RESULTS: Flow cytometry analysis showed that LA-N-6 cells expressed Foxp3 at a high level. At sub-optimal concentration, chemotherapy drugs CTX and THP significantly down-regulated expression of Foxp3 on LA-N-6 cells at protein level (P<0.05). CTX also decreased the expression of Foxp3 at mRNA level (P<0.05). CONCLSUSIONS: Neuroblastoma cells LA-N-6 express Foxp3 at a high level, which can be suppressed by chemotherapy drugs CTX and THP. These data suggest that chemotherapy might suppress the growth and metastasis of tumor cells partially through inhibiting the expression of Foxp3.［Chin J Contemp Pediatr, 2010, 12 (5):386-389］
Foxp3 / 神经母细胞瘤 / 环磷酰胺 / 盐酸吡柔比星 / LA-N-6细胞株
Foxp3 / Neuroblastoma / Cyclophosvnamide / Pirarubicin / LA-N-6 cell
［1］Weigel D, Jackle H. The fork head domain: a novel DNA bindingmotif of eukaryotic transcription factors?［J］. Cell, 1990, 63(3):455-456.
［2］Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FoxP3［J］. Science, 2003, 299(5609):1057-1061.
［3］Ebert LM, Tan BS, Browning J, Svobodova S, Russell SE, Kirkpatrick N,et al. The regulatory T cell-associated transcription factor Foxp3 is expressed by tumor cells［J］. Cancer Res, 2008, 68(8):3001-3009.
［4］Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grüssel S, Sipos B, et al. Foxp3 expression in Pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer［J］. Cancer Res, 2007, 67(17):8344-8350.
［5］Viguier M, Lemaitre F, Verola O, Cho MS, Gorochov G, Dubertret L, et al. FoxP3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells［J］. J Immunol, 2004, 173(2):1444-1453.
［6］de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, et al. CD4+CD25(bright) regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis［J］. J Immunol, 2004, 172(10):6435-6443.
［7］Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Kawano R, Suzumiya J, et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells［J］. Br J Haematol, 2004, 126(1):81-84.
［8］Prakken BJ, Samodal R, Le TD, Giannoni F, Yung GP, Scavulli J, et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis［J］. Proc Natl Acad Sci U S A, 2004, 101(12):4228-4233.
［9］Brunkow ME, Jeffery EW, Hjerrild KA. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse［J］. Nat Genet, 2001, 27(1):68-73.
［10］ Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3［J］. Immunity, 2005, 22(3):329-341.
［11］Zuo T, Wang L, Morrison C. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene［J］. Cell, 2007, 129(7):1275-1286.
［12］Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity［J］. Curr Opin Immunol, 2009, 21(6):612-618.
［13］Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation［J］. J Biol Chem, 2001, 276（40）:37672-37679.
